Since miR-361 was highly expressed in pancreatic cancer, and miRNAs usually inhibit the expression of target genes, we speculated that miR-361-3p may target BTG2 in pancreatic cancer. This evidence concerns the gene BTG2 and pancreatic neoplasm.